PALI — Palisade Bio Balance Sheet
0.000.00%
- $7.30m
- $0.08m
Annual balance sheet for Palisade Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 10.5 | 10.5 | 12.4 | 12.4 | 9.82 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.116 | 0.15 | 1.44 | 0.148 | 0.024 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 12.9 | 11.5 | 14.7 | 13.3 | 10.5 |
| Net Property, Plant And Equipment | 0.011 | 0.112 | 0.31 | 0.208 | 0.087 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 13 | 12.5 | 15.8 | 14.1 | 10.9 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 3.21 | 2.5 | 3.01 | 2.59 | 3.24 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 3.28 | 5.15 | 3.28 | 2.74 | 3.39 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 9.77 | 7.37 | 12.5 | 11.3 | 7.49 |
| Total Liabilities & Shareholders' Equity | 13 | 12.5 | 15.8 | 14.1 | 10.9 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |